PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2021 Financial Results

 

 

SOUTH PLAINFIELD, N.J., July 15, 2021 /PRNewswire/ --PTC Therapeutics, Inc.,  (NASDAQ: PTCT) today announced that the Company will host a webcast conference call to report its second quarter 2021 financial results and provide an update on the company's business and outlook on Thursday, July 29, 2021, at 4:30 p.m. (ET) after the closing of the market.

The call can be accessed by dialing (877) 303-9216 (domestic) or (973) 935-8152 (international) five minutes prior to the start of the call and providing the passcode 7064479. A live, listen-only webcast of the conference call can be accessed on the investor relations section of the PTC website at https://ir.ptcbio.com/events-presentations.  A webcast replay of the call will be available approximately two hours after completion of the call and will be archived on the company's website for 30 days following the call.

About PTC Therapeutics, Inc.
PTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need. The Company's strategy is to leverage its strong scientific expertise and global commercial infrastructure to maximize value for its patients and other stakeholders.

 

FOR MORE INFORMATION PLEASE CONTACT:

Media:

Investors:

Jane Baj

Kylie O'Keefe

+1 (908) 912-9167

+1 (908) 300-0691

jbaj@ptcbio.com

kokeefe@ptcbio.com 

 

Cision View original content:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-host-conference-call-to-discuss-second-quarter-2021-financial-results-301333992.html

SOURCE PTC Therapeutics, Inc.

 
 
Company Codes: NASDAQ-NMS:PTCT
 

Back to news